Zdrowie i gospodarka · 02/10/2012

FDA Releases Draft Guidance on Initial Completeness Assessments for Type II API DMFs Under GDUFA

The FDA is announcing a draft guidance for industry on initial completeness assessments for Type II active pharmaceutical ingredient drug master files, which are required under the Generic Drug User Fee Amendments of 2012, to clarify the criteria the agency will use for these assessments.